ZNF285
Basic information
Region (hg38): 19:44382298-44401608
Previous symbols: [ "ZNF285A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF285 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 34 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 10 | 0 |
Variants in ZNF285
This is a list of pathogenic ClinVar variants found in the ZNF285 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-44386494-T-C | not specified | Uncertain significance (Dec 02, 2022) | ||
19-44386515-A-G | not specified | Uncertain significance (Nov 15, 2021) | ||
19-44386523-T-C | Likely benign (Apr 01, 2023) | |||
19-44386663-T-C | not specified | Uncertain significance (Feb 27, 2024) | ||
19-44386725-A-G | not specified | Likely benign (Jun 11, 2021) | ||
19-44386737-T-C | not specified | Uncertain significance (Apr 29, 2024) | ||
19-44386782-A-C | not specified | Uncertain significance (Jul 15, 2021) | ||
19-44386786-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
19-44386812-T-G | not specified | Uncertain significance (Dec 14, 2022) | ||
19-44386818-C-A | not specified | Uncertain significance (May 14, 2024) | ||
19-44386842-C-G | not specified | Uncertain significance (Apr 30, 2024) | ||
19-44386954-C-T | not specified | Uncertain significance (Jan 03, 2022) | ||
19-44386981-G-C | not specified | Uncertain significance (Aug 14, 2023) | ||
19-44387019-A-C | not specified | Uncertain significance (May 22, 2023) | ||
19-44387049-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
19-44387056-C-T | not specified | Uncertain significance (Nov 30, 2021) | ||
19-44387096-C-G | not specified | Uncertain significance (Aug 16, 2021) | ||
19-44387106-C-G | not specified | Uncertain significance (Feb 28, 2023) | ||
19-44387112-C-G | not specified | Uncertain significance (Oct 14, 2023) | ||
19-44387169-A-G | not specified | Uncertain significance (Apr 18, 2023) | ||
19-44387202-T-A | not specified | Likely benign (Nov 17, 2022) | ||
19-44387202-T-G | not specified | Likely benign (Dec 17, 2021) | ||
19-44387203-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
19-44387206-C-T | not specified | Likely benign (Jan 26, 2022) | ||
19-44387214-T-C | not specified | Uncertain significance (Mar 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF285 | protein_coding | protein_coding | ENST00000330997 | 3 | 19316 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000167 | 0.702 | 125707 | 0 | 36 | 125743 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.27 | 367 | 304 | 1.21 | 0.0000159 | 3931 |
Missense in Polyphen | 50 | 52.013 | 0.9613 | 744 | ||
Synonymous | -0.669 | 119 | 110 | 1.08 | 0.00000568 | 1019 |
Loss of Function | 0.905 | 7 | 10.1 | 0.693 | 4.95e-7 | 140 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000514 | 0.000514 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000185 | 0.000185 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 1.91
- rvis_percentile_EVS
- 97.42
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.158
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | Medium | High |
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;metal ion binding